Pfizer Begins Four-State Trial Delivery For COVID-19 Vaccine

Pfizer, a pharmaceutical company that recently publicly said they did not receive money from the US government and that they were not involved in Operation Warp Speed, has launched a pilot program for delivery of its experimental coronavirus vaccine in four states: Rhode Island, Texas, New Mexico and Tennessee.  According to a report, the company chose those four states to test any distribution challenges that may arise amid ultra-cold storage requirements.  During an update on Operation Warp Speed last week, President Donald Trump said that the Pfizer representative’s words were an “unfortunate misrepresentation.”

Here’s the rub.  Pfizer’s vaccine, which has gotten results of being more than 90 percent effective, has to be shipped and stored at minus 94°F, which is undoubtedly below the standard temperature for vaccines that is normally between 36-46°F.

UBS analysts have predicted that between approximately 5 and 10 percent of Pfizer’s vaccine may become ineffective “due to inadequate storage conditions.”

According to Reuters, roughly a third of US states are now purchasing ultra-cold storage equipment.  Manufacturers are assuming months-long back-orders and delays for the products, that can range in costs from $5,000 to $15,000 due to unprecedented demand.

That’s a small price to pay for saving lives and helping to eradicate the over-hyped coronavirus that has a 99 percent survival rate.  In fact, this particular virus has helped the world morph into an Orwellian dystopian nightmare with politicians and the usual suspect media types to support them, using the hype of the virus to push for mail-in voting in the United States in an effort to cheat in the 2020 election, something we are having to deal with today.

They also used the virus to usher in the tyrants of Democrat-run states where rules only apply to citizens the dictators disagree with politically.  We have also learned that coronavirus is the only intelligent virus that takes sides politically having infected citizens who protest to be able to open their small businesses in the wake of draconian lockdowns to feed their children while never affecting people who protest, loot, riot and burn cities to the ground because of the death of George Floyd, which later turned into a movement to push for Marxism in America.  But I digress.

“We are hopeful that results from this vaccine delivery pilot will serve as the model for other US states and international governments, as they prepare to implement effective COVID-19 vaccine programs,” Pfizer said in a statement Monday.

The four states were chosen by taking into account the differences in size, in diversity of populations, and immunization infrastructures, etc., along with the ability to be able to reach people in urban and rural settings alike.

Pfizer was clear that none of the four chosen states will have doses delivered sooner than anywhere else in the United States because of the pilot program, and they will get the same considerations as everyone else.

The pharmaceutical company predicts that they will have enough safety data on the inoculation from the late-stage trials by the 3rd week of November prior to moving toward applying for emergency use authorization.  Will we experience deep state politics in the interim that will create a lot of government red tape in the never-ending quest to make President Trump and his administration look bad?  Who knows, but the odds are in favor of it.

Even though Pfizer said they received no money from the federal government, they were given a deal worth $1.95 billion to distribute 100 million dozes to the federal government, and there is an option to disperse 500 million more doses.

On Monday, Moderna, an American biotechnology company based in Cambridge, Massachusetts that focuses on drug discovery, drug development, and vaccine technologies, made an announcement that their vaccine is 94.5 percent effective in late-stage trials, and that unlike Pfizer’s vaccine, Moderna’s is stable for up to one month at standard refrigeration temperatures.